Ben Atkins | Vice President, Communications and Investor Relations |
Roger Crystal | President and Chief Executive Officer |
Matt Ruth | Chief Commercial Officer |
David O'Toole | Chief Financial Officer |
Brandon Folkes | Cantor Fitzgerald |
Carl Byrnes | Northland Capital Markets |
David Bautz | Zacks |
00:03 Greetings, and welcome to the Opiant Pharmaceuticals Fourth Quarter and Full-Year 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. 00:26 It is now my pleasure to introduce your host Ben Atkins, Vice President of Investor Communications and Investor Relations of Opiant Pharmaceuticals.